Welcome to LookChem.com Sign In|Join Free
  • or
3,6-bis-(4-methoxyphenyl)-1H-pyrazin-2-one is a chemical compound with the molecular formula C18H16N2O4. It is a derivative of pyrazin-2-one, featuring two 4-methoxyphenyl groups attached to the 3 and 6 positions of the pyrazine ring. 3,6-bis-(4-methoxyphenyl)-1H-pyrazin-2-one is known for its potential applications in the field of pharmaceuticals and materials science, particularly as a building block for the synthesis of more complex molecules. Its structure endows it with unique electronic and steric properties, which can be exploited in the design of new drugs or other chemical products. The compound is typically synthesized through organic chemistry methods, and its properties, such as solubility and reactivity, can be further investigated for specific applications.

1097-19-4

Post Buying Request

1097-19-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1097-19-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1097-19-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,9 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1097-19:
(6*1)+(5*0)+(4*9)+(3*7)+(2*1)+(1*9)=74
74 % 10 = 4
So 1097-19-4 is a valid CAS Registry Number.

1097-19-4Downstream Products

1097-19-4Relevant academic research and scientific papers

Design and synthesis of 2(1H)-pyrazinones as inhibitors of protein kinases

Caldwell, John J.,Veillard, Nicolas,Collins, Ian

, p. 9713 - 9728,16 (2012/12/11)

Kinase enzymes play a key role in the development and progression of cancer. Inhibitors of deregulated kinases are effective small molecule anticancer drugs. The 2(1H)-pyrazinone heterocycle is a previously unexploited motif that can fulfil the structural requirements for ATP-competitive inhibition of kinases. Rapid solution-phase syntheses of novel 3,5- and 3,6-disubstituted-2(1H)-pyrazinones were developed through selective, sequential substitution of 2,5-dihalo-3-benzyloxypyrazine and 3,5-dihalo-2(1H)-pyrazinone intermediates. Palladium-catalysed cross-couplings and SNAr reactions were used to introduce substituents chosen on the basis of the calculated physicochemical properties of the target pyrazinones. Representative compounds demonstrated good solubility, kinase inhibitory activity and antiproliferative activity in human tumour cells, confirming the suitability of this chemical class as a kinase-focused library.

Design and synthesis of 2(1H)-pyrazinones as inhibitors of protein kinases

Caldwell, John J.,Veillard, Nicolas,Collins, Ian

, p. 9713 - 9728 (2013/01/13)

Kinase enzymes play a key role in the development and progression of cancer. Inhibitors of deregulated kinases are effective small molecule anticancer drugs. The 2(1H)-pyrazinone heterocycle is a previously unexploited motif that can fulfil the structural requirements for ATP-competitive inhibition of kinases. Rapid solution-phase syntheses of novel 3,5- and 3,6-disubstituted-2(1H)-pyrazinones were developed through selective, sequential substitution of 2,5-dihalo-3-benzyloxypyrazine and 3,5-dihalo-2(1H)-pyrazinone intermediates. Palladium-catalysed cross-couplings and SNAr reactions were used to introduce substituents chosen on the basis of the calculated physicochemical properties of the target pyrazinones. Representative compounds demonstrated good solubility, kinase inhibitory activity and antiproliferative activity in human tumour cells, confirming the suitability of this chemical class as a kinase-focused library.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1097-19-4